Article From: "Max Stendahl"   Read full article

Back in January, Bedford-based Anika Therapeutics disclosed in a one-sentence federal filing that one of its top executives, chief medical officer Stephen Mascioli, had left the company after less than a year on the job. A new filing suggests that the split was far from amicable.

Anika (Nasdaq: ANIK) said Friday that it had agreed to pay Mascioli $350,000 for “alleged damages and attorneys’ fees,” including $250,000 for alleged lost wages. While the filing did not disclose the nature of Mascioli’s…